Transient exacerbation of tuberculous lymphadenitis during chemotherapy in patients with AIDS

Clin Infect Dis. 1994 Oct;19(4):774-6. doi: 10.1093/clinids/19.4.774.

Abstract

We describe three men with disseminated, drug-sensitive tuberculosis and advanced human immunodeficiency virus disease (CD4+ lymphocyte count, < 50/mm3) who had flares of tuberculous lymphadenitis with suppuration during the initial weeks of successful chemotherapy. Bactericidal drugs may kindle these transient exacerbations, which involve neutrophils but apparently do not require normal helper T cell function. In patients with AIDS, as in immunocompetent individuals, treatment-related flares of lymphadenitis are usually not an adverse sign, provided that drug resistance and nonadherence have been excluded.

Publication types

  • Case Reports

MeSH terms

  • AIDS-Related Opportunistic Infections / drug therapy*
  • AIDS-Related Opportunistic Infections / immunology
  • Adult
  • Antitubercular Agents / therapeutic use*
  • Ethambutol / therapeutic use
  • Humans
  • Isoniazid / therapeutic use
  • Leukocyte Count
  • Male
  • Pyrazinamide / therapeutic use
  • Rifampin / therapeutic use
  • Tuberculosis, Lymph Node / drug therapy*
  • Tuberculosis, Lymph Node / immunology
  • Tuberculosis, Multidrug-Resistant / drug therapy*
  • Tuberculosis, Multidrug-Resistant / immunology

Substances

  • Antitubercular Agents
  • Pyrazinamide
  • Ethambutol
  • Isoniazid
  • Rifampin